Growth Metrics

Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2020 - 2025)

Historic Non-Current Deferred Tax Liability for Gilead Sciences (GILD) over the last 10 years, with Q3 2025 value amounting to $597.0 million.

  • Gilead Sciences' Non-Current Deferred Tax Liability fell 2481.11% to $597.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $597.0 million, marking a year-over-year decrease of 2481.11%. This contributed to the annual value of $724.0 million for FY2024, which is 8780.94% down from last year.
  • As of Q3 2025, Gilead Sciences' Non-Current Deferred Tax Liability stood at $597.0 million, which was down 2481.11% from $652.0 million recorded in Q2 2025.
  • In the past 5 years, Gilead Sciences' Non-Current Deferred Tax Liability ranged from a high of $7.1 billion in Q4 2021 and a low of $597.0 million during Q3 2025
  • Its 5-year average for Non-Current Deferred Tax Liability is $2.9 billion, with a median of $2.4 billion in 2023.
  • Per our database at Business Quant, Gilead Sciences' Non-Current Deferred Tax Liability skyrocketed by 861.23% in 2021 and then crashed by 8780.94% in 2024.
  • Over the past 5 years, Gilead Sciences' Non-Current Deferred Tax Liability (Quarter) stood at $7.1 billion in 2021, then fell by 14.23% to $6.1 billion in 2022, then dropped by 2.99% to $5.9 billion in 2023, then tumbled by 87.81% to $724.0 million in 2024, then fell by 17.54% to $597.0 million in 2025.
  • Its Non-Current Deferred Tax Liability stands at $597.0 million for Q3 2025, versus $652.0 million for Q2 2025 and $709.0 million for Q1 2025.